$12.8 Million Available in Grants/Cooperative Agreements for Kidney Cancer Clinical Trials
Grants
Copyright © Targeted News Service, 2021
Copyright © Targeted News Service, 2021
2021-06-15
by MYRA TUGADE
WASHINGTON, June 15 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to four grants or cooperative agreements for kidney cancer clinical trials.
The agency description of the grant/cooperative agreement states: "The KCRP Clinical Trial Award supports the rapid implementation of early-phase clinical trials (phase 0, phase 1, phase 1/2) with the potential to have a significant impact on the treatment or management of kidney cancer. Clinical . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 15 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to four grants or cooperative agreements for kidney cancer clinical trials.
The agency description of the grant/cooperative agreement states: "The KCRP Clinical Trial Award supports the rapid implementation of early-phase clinical trials (phase 0, phase 1, phase 1/2) with the potential to have a significant impact on the treatment or management of kidney cancer. Clinical . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com